Ranking · Summer 2019 · Healthcare · Drug Discovery and Delivery

Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

4.8%

odds of being acquired in the next two years

0.7× the average (6.8%)

#3628 of 4,339 active YC companies · top 85%

Team of 52 · St. John's, NL, Canada

Raises the odds

↑ based in America / Canada

↑ based in Remote

Lowers the odds

↓ industry: Healthcare

↓ sector: Drug Discovery and Delivery

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Sequence Bio's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

sequencebio.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub